An Open-label Safety and Tolerability Study of LTS 0.3% With Red Light Applied to the Backs of Healthy Volunteers

Trial Profile

An Open-label Safety and Tolerability Study of LTS 0.3% With Red Light Applied to the Backs of Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2013

At a glance

  • Drugs Lemuteporfin (Primary)
  • Indications Acne vulgaris; Benign prostatic hyperplasia; Male pattern baldness
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Aug 2013 New trial record
    • 24 Jul 2013 Status changed from recruiting to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top